... Food and Drug Administration also recently approved another targeted therapy, Ukoniq (umbralisib), to treat marginal zone lymphomas like MALT lymphoma. Surgery and radiation therapy may also be used to treat MALT lymphoma that doesn’t respond to drug therapy. ...
... Food and Drug Administration also recently approved another targeted therapy, Ukoniq (umbralisib), to treat marginal zone lymphomas like MALT lymphoma. Surgery and radiation therapy may also be used to treat MALT lymphoma that doesn’t respond to drug therapy. ...
... Targeted therapies such as Rituxan (rituximab), Imbruvica (ibrutinib), and Ukoniq (umbralisib) may be used with chemotherapy. Treating Gastric DLBCLDLBCL is a high-grade lymphoma that needs to be treated with more aggressive therapies. ...
... Targeted therapies such as Rituxan (rituximab), Imbruvica (ibrutinib), and Ukoniq (umbralisib) may be used with chemotherapy. Treating Gastric DLBCLDLBCL is a high-grade lymphoma that needs to be treated with more aggressive therapies. ...